Regulation of the body fat percentage in developmental-stage rats by methylxanthine derivatives in a high-fat diet

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 5, 2006, Pages 1134-1139

  Inoue, Hiroko ^a   Kobayashi Hattori, Kazuo ^a   Horiuchi, Yumi ^a   Oishi, Yuichi ^b   Arai, Souichi ^a   Takita, Toshichika ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^b CHUBU UNIVERSITY   (Japan)

Author keywords

Abdominal adipose tissue; Body fat percentage; High fat diet; Methylxanthine derivative; Rat

Indexed keywords

BIODIVERSITY; DISEASES; NUTRITION; TISSUE; TOXIC MATERIALS;

ABDOMINAL ADIPOSE TISSUE; BODY FAT PERCENTAGE; HIGH-FAT DIET; METHYLXANTHINE DERIVATIVE; RAT;

CARBOHYDRATES;

CAFFEINE; CHOLESTEROL; METHYLXANTHINE; THEOBROMINE; THEOPHYLLINE; TRIACYLGLYCEROL; XANTHINE DERIVATIVE;

ABDOMINAL FAT; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CHEMISTRY; DIET; DRUG EFFECT; EATING; FAT INTAKE; LIVER; MALE; RAT; SPRAGUE DAWLEY RAT;

ABDOMINAL FAT; ANIMALS; BODY WEIGHT; CAFFEINE; CHOLESTEROL; DIET; DIETARY FATS; EATING; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; THEOBROMINE; THEOPHYLLINE; TRIGLYCERIDES; XANTHINES;

EID: 33646804558     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70.1134     Document Type: Article

References (34)

1. Health and welfare statistics association: association of health and welfare statistics. Kousei no Shihyo (Trends for National Health and Hygiene) (in Japanese), 51, 45-52 (2004).
2. Reaven, G. M., Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595-1607 (1988).
3. Kaplan, N. M., The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med., 149, 1514-1520 (1989).
4. DeFronzo, R. A., and Ferrannini, E., Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-194 (1991).
5. Nakamura, T., Tokunaga, K., Shimomura, I., Nishida, M., Yoshida, S., Kotani, K., Islam, A. H., Keno, Y., Kobatake, T., Nagai, Y., Fujioka, S., Tarui, S., and Matsuzawa, Y., Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis, 107, 239-246 (1994).
6. Inoue, H., Kobayashi-Hattori, K., Yamabe, S., Taniguchi, H., and Takita, T., Reducing effect of theophylline on the body fat and serum triacylglyceride in rats fed a high-fat diet. ITE Lett. Batt. New Technol. Med., 6, 61-67 (2005).
7. Kobayashi-Hattori, K., Mogi, A., Matsumoto, Y., and Takita, T., Effect of caffeine on the body fat and lipid metabolism in rats fed on a high-fat diet. Biosci. Biotechnol. Biochem., 69, 2219-2223 (2005).
8. Wilcox, A. R., The effects of caffeine and exercise on body weight, fat-pad weight, and fat-cell size. Med. Sci. Sports Exerc., 14, 317-321 (1982).
9. Hongu, N., and Sachan, D. S., Caffeine, carnitine and choline supplementation of rats decreases body fat and serum leptin concentration as does exercise. J. Nutr., 130, 152-157 (2000).
10. 14C. J. Biol. Chem., 244, 2252-2260 (1969).
11. George, A. B., Stella, M., and Andrea, S. C., Mobilization of fatty acid in genetically obese rats. J. Lipid Res., 11, 517-521 (1970).
12. Komabayashi, T., Sakamoto, S., and Tsuboi, M., Effects of various drugs on the lipolytic actions caused by catecholamines and methylxanthine derivatives in white adipose tissues. 1. Effects of procaine and xylocaine. Folia Pharmacol. Japon., 74, 459-466 (1978).
13. Suzuki, M., Shimomura, Y., and Satoh, Y., Diurnal changes in lipolytic activity of isolated fat cells and their increased responsiveness to epinephrine and theophylline with meal feeding in rats. J. Nutr. Sci. Vitaminol., 29, 399-411 (1983).
14. Morimoto, C., Kameda, K., Tsujita, T., and Okuda, H., Relationships between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells. J. Lipid Res., 42, 120-127 (2001).
15. American Institute of Nutrition, Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J. Nutr., 107, 1340-1348 (1977).
16. Duncan, D. B., Multiple range and multiple F tests. Biometrics, 11, 1-42 (1955).
17. Kotani, K., Nishida, M., Yamashita, S., Funahashi, T., Fujioka, S., Tokunaga, K., Ishikawa, K., Tarui, S., and Matsuzawa, Y., Two decades of annual medical examinations in Japanese obese children: do obese children grow into obese adults? Int. J. Obes. Relat. Metab. Disord., 21, 912-921 (1997).
18. Togashi, K., Masuda, H., Rankinen, T., Tanaka, S., Bouchard, C., and Kamiya, H., A 12-year follow-up study of treated obese children in Japan. Int. J. Obes. Relat. Metab. Disord., 26, 770-777 (2002).
19. Klish, W. J., Childhood obesity: pathophysiology and treatment. Acta Paediatr. Jpn., 37, 1-6 (1995).
20. Shimomura, I., Funahashi, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., Miura, M., Fukuda, Y., Takemura, K., Tokunaga, K., and Matsuzawa, Y., Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med., 2, 800-803 (1996).
21. Matsuzawa, Y., Adipocytokines and metabolic syndrome. Semin. Vasc. Med., 5, 34-39 (2005).
22. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., and Spiegelman, B. M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science, 271, 665-668 (1996).
23. Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., and Goldstein, J. L., Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature, 401, 73-76 (1999).
24. Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y., Brown, M. S., and Goldstein, J. L., Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell, 6, 77-86 (2000).
25. Pyorala, K., Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care, 2, 131-141 (1979).
26. Welborn, T. A., and Wearne, K., Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care, 2, 154-160 (1979).
27. Ducimetiere, P., Eschwege, E., Papoz, L., Richard, J. L., Claude, J. R., and Rosselin, G., Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia, 19, 205-210 (1980).
28. Zheng, G., Sayama, K., Okubo, T., Juneja, L. R., and Oguni, I., Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo, 18, 55-62 (2004).
29. Kannel, W. B., Castelli, W. P., Gordon, T., and McNamara, P. M., Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann. Intern. Med., 74, 1-12 (1971).
30. Grundy, S. M., Cholesterol and coronary heart disease. A new era. JAMA, 256, 2849-2858 (1986).
31. Stamler, J., Wentworth, D., and Neaton, J. D., Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA, 256, 2823-2828 (1986).
32. Iso, H., Naito, Y., Sato, S., Kitamura, A., Okamura, T., Sankai, T., Shimamoto, T., Iida, M., and Komachi, Y., Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am. J. Epidemiol., 153, 490-499 (2001).
33. Hokanson, J. E., and Austin, M. A., Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk, 3, 213-219 (1996).
34. Stavric, B., Klassen, R., Watkinson, B., Karpinski, K., and Stapley, R., Variability in caffeine consumption from coffee and tea: possible significance for epidemiological studies. Food Chem. Toxicol., 26, 111-118 (1988).